Salmonella Typhi and Salmonella Paratyphi prevalence, antimicrobial susceptibility profile and factors associated with enteric fever infection in Bahir Dar, Ethiopia
- PMID: 33795754
- PMCID: PMC8016905
- DOI: 10.1038/s41598-021-86743-9
Salmonella Typhi and Salmonella Paratyphi prevalence, antimicrobial susceptibility profile and factors associated with enteric fever infection in Bahir Dar, Ethiopia
Abstract
Enteric fever (EF) is caused by Salmonella enterica serovars Typhi (S. Typhi) and Paratyphi (S. Paratyphi) causing significant health problems in developing countries including Ethiopia. Thus present study aimed to determine prevalence and antimicrobial resistance profile of S. Typhi and S. Paratyphi among EF suspected patients at Felege-Hiwot comprehensive specialized hospital, Bahir Dar, Ethiopia. Hospital based cross-sectional study was conducted from March-to-May 2020. Totally, 150 patients were included conveniently. Data were collected using questionnaires by face-to-face interview. Concurrently, venous blood and stool specimens were collected and processed following standard bacteriological technique. Antimicrobial susceptibility test (AST) was performed by disc diffusion method. Logistic regression was performed to identify factors associated with EF infection. The study indicated 5.3% EF prevalence where S. Typhi accounted 75%. S. Typhi and S. Paratyphi isolates were 100% sensitive to cephalosporins but at least 83.3% showed resistance against chloramphenicol and tetracycline. At least 66.7% of isolates were multidrug resistance (MDR). Using well water for drinking (AOR = 6.22, CI 1.4-27.5) and previous EF history (AOR = 10.74, CI 2.01-55.9) were significantly associated with EF infection. Thus high bacterial prevalence and MDR isolates was observed. Therefore, health professionals should consider AST and use antibiotics with cautions for EF patient management.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar typhi and paratyphi A.Indian J Med Microbiol. 2006 Apr;24(2):101-6. doi: 10.4103/0255-0857.25182. Indian J Med Microbiol. 2006. PMID: 16687859
-
Prevalence of Salmonella Typhi, its associated factors and antimicrobial susceptibility profile among patients attending Hawassa University Comprehensive Specialized Hospital, Hawassa, Ethiopia.BMC Infect Dis. 2024 Oct 31;24(1):1224. doi: 10.1186/s12879-024-10118-4. BMC Infect Dis. 2024. PMID: 39482629 Free PMC article.
-
Antimicrobial susceptibility patterns of Salmonella typhi and Salmonella paratyphi A in a tertiary care hospital.J Nepal Health Res Counc. 2012 Sep;10(22):214-7. J Nepal Health Res Counc. 2012. PMID: 23281454
-
Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis.BMC Med. 2020 Jan 3;18(1):1. doi: 10.1186/s12916-019-1443-1. BMC Med. 2020. PMID: 31898501 Free PMC article.
-
Antimicrobial resistance in Salmonella enterica serovar typhi and paratyphi in South Asia-current status, issues and prospects.Crit Rev Microbiol. 2015;41(4):536-45. doi: 10.3109/1040841X.2014.880662. Epub 2014 Mar 19. Crit Rev Microbiol. 2015. PMID: 24645636 Review.
Cited by
-
Prevalence and antimicrobial susceptibility level of typhoid fever in Ethiopia: A systematic review and meta-analysis.Prev Med Rep. 2021 Dec 13;25:101670. doi: 10.1016/j.pmedr.2021.101670. eCollection 2022 Feb. Prev Med Rep. 2021. PMID: 34976707 Free PMC article.
-
Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now?Infect Drug Resist. 2022 Jul 7;15:3589-3609. doi: 10.2147/IDR.S342753. eCollection 2022. Infect Drug Resist. 2022. PMID: 35837538 Free PMC article. Review.
-
Fighting the enemy within: Systemic immune defense against mucosal Salmonella infection.Immunol Lett. 2024 Dec;270:106930. doi: 10.1016/j.imlet.2024.106930. Epub 2024 Sep 27. Immunol Lett. 2024. PMID: 39343314 Free PMC article. Review.
-
Emerging Trends of Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) Salmonella Typhi in a Tertiary Care Hospital of Lahore, Pakistan.Microorganisms. 2021 Nov 30;9(12):2484. doi: 10.3390/microorganisms9122484. Microorganisms. 2021. PMID: 34946085 Free PMC article.
-
A Systematic review on Prevalence, Serotypes and Antibiotic resistance of Salmonella in Ethiopia, 2010-2022.Infect Drug Resist. 2023 Oct 13;16:6703-6715. doi: 10.2147/IDR.S424345. eCollection 2023. Infect Drug Resist. 2023. PMID: 37854471 Free PMC article. Review.
References
-
- Adesegun OA, Adeyemi OO, Ehioghae O, Rabor DF, Binuyo TO, Alafin BA, et al. Current trends in the epidemiology and management of enteric fever in Africa: A literature review. Asian Pac. J. Trop. Med. 2020;13(5):204–213. doi: 10.4103/1995-7645.283515. - DOI
-
- World Health Organization. Typhoid fever. 2018. Available at: https://www.who.int/news-room/fact-sheets/detail/typhoid Accessed on: January 2020.
-
- World Health Organization. Vaccine Preventable disease surveillance standards- Typhoid and other invasive salmonellosis. Available at: https://www.who.int/drugresistance/documents/surveillancereport/en/ Accessed on February 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases